Showing 6351-6360 of 7080 results for "".
- Concern About Zika Virus in US Set to Escalatehttps://practicaldermatology.com/news/concern-about-zika-virus-in-us-set-to-escalate/2458751/U.S dermatologists may start to receive calls from patients who are concerned about infection with Zika virus – particularly pregnant ones. Zika is now spreading rapidly across Latin America and the Caribbean. So far, one case has been identified in Houston, but the possibility
- Almirall Exercises Call Option to Acquire ThermiGenhttps://practicaldermatology.com/news/almirall-exercises-call-option-to-acquire-thermigen/2458755/Barcelona pharma company Almirall, S.A., is stepping up their plans to take on ThermiGen LLC. The company is now exercising their call option to acquire 100 percent of the share capital of ThermiGen.
- Ranbaxy Launches Patient Education Resources for Acne Patients Featuring Athlete Kelly Clarkhttps://practicaldermatology.com/news/ranbaxy-launches-patient-education-resources-for-acne-patients-featuring-athlete-kelly-clark/2458758/Ranbaxy Laboratories Inc, a SUN PHARMA company, has launched of a variety of patient education resources featuring gold medal-winning snowboarder and 2015 ESPY Best Female Action Sports Athlete Kelly Clark. The tools are housed on ABSORICA.COM. Absorica<
- Allergan Expands Neurotoxin Pipeline with Anterios Acquisitionhttps://practicaldermatology.com/news/allergan-expands-neurotoxin-pipelinewith-anterios-acquisition/2458763/Allergan plc has acquired Anterios, Inc., a clinical stage biopharmaceutical company developing a next generation delivery system and botulinum toxin-based prescription products. Under the terms of the agreement, Allergan acquired Anterios for an upfront payment of $90 million and potential devel
- Paratek To Complete Omadacycline Phase 3 Skin Trial Earlier Than Expectedhttps://practicaldermatology.com/news/paratek-completes-enrollment-for-omadacycline-phase-3-skin-trial-earlier-than-expected/2458767/Paratek Pharmaceuticals, Inc. may report top-line data from its ongoing pivotal Phase 3 clinical trial evaluating omadacycline for the treatment of Acute Bacterial Skin and Skin Structure Infections (ABSSS
- Valeant Announces J. Michael Pearson Will Be On Medical Leave of Absencehttps://practicaldermatology.com/news/valeant-announces-j-michael-pearson-will-be-on-medical-leave-of-absence/2458770/Valeant Pharmaceuticals International, Inc. announced that chairman and chief executive officer J. Michael Pearson will be on a medical leave of absence, effective immediately. The company's board of directors has created an Office of the Chief Executive Officer, which will include Robert Cha
- Practical Dermatology Preview: Drug Companies, Insurance Companies, Pharmacists, the Government, Doctors and…Oh, Patients!https://practicaldermatology.com/news/practical-dermatology-preview-drug-companies-insurance-companies-pharmacists-the-government-doctors-andoh-patients/2458774/Recently, a relationship between Valeant Pharmaceuticals and a specialty pharmacy, Philidor, was revealed, with significant consequences to Valeant and equally significant consequences for the pharmacy. The full story is still unfolding as of this time, but the interpretations of these type
- Strathspey Crown Appointments Murthy Simhambhatla, PhD, as Senior Partnerhttps://practicaldermatology.com/news/strathspey-crown-appointments-murthy-simhambhatla-phd-as-senior-partner/2458776/Strathspey Crown Holdings LLC announced the appointment of Murthy Simhambhatla, PhD as a Senior Partner of the firm. Dr. Simhambhatla has more than 20 years of experience in bioscience and has built a successful track record in the healthcare industry. Dr. Simhambhatla was
- Valeant Issues Updated Financial Guidancehttps://practicaldermatology.com/news/valeant-issues-updated-financial-guidance/2458779/Valeant Pharmaceuticals International, Inc. announced updated financial guidance for the fourth quarter and full year 2015 as well as new guidance for full year 2016. "We are very excited about the strong future given our broad portfolio of brands, our upcoming launch products and ou
- Galderma and ZELTIQ Announce US Collaboration in Aestheticshttps://practicaldermatology.com/news/galderma-and-zeltiq-announce-us-collaboration-in-aesthetics/2458785/Galderma and ZELTIQ Aesthetics, Inc. entered into a new collaboration across the companies’ innovative aesthetic brands and offerings. Effective immediately, the creation of this nationwide collaboration will provide healthcare professionals and consumers with greater access to a robust ran